Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at CZK 437.7B, ahead of Merck & Co (CZK 323.5B) and Novartis (CZK 254B). Figures as of 18 Nov 2026, 22:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonCZK 437.7B
- Median
- CZK 12.7B
- Combined market value
- CZK 112.36T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CZK 437.7B | CZK 14.58T | CZK 6,056.67 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | CZK 323.5B | CZK 7.54T | CZK 3,060.09 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | CZK 254B | CZK 6.51T | CZK 3,447.21 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | CZK 226.7B | CZK 2.7T | CZK 1,322.83 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | CZK 189.3B | CZK 4.02T | CZK 2,320.50 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | CZK 188.7B | CZK 2.51T | CZK 1,046.54 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | CZK 161.4B | CZK 27.36T | CZK 30,710.88 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | CZK 126.8B | CZK 6.16T | CZK 3,970.26 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | CZK 116.1B | CZK 11.23T | CZK 6,352.28 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | CZK 112.9B | CZK 3.02T | CZK 11,914.55 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | CZK 101B | CZK 1.02T | CZK 8,963.96 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | CZK 100.1B | CZK 2.16T | CZK 1,078.96 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | CZK 87.2B | CZK 3.86T | CZK 875.74 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | CZK 82.8B | CZK 1.51T | CZK 472.41 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 79B | CZK 1.09T | CZK 937.93 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | CZK 69.3B | CZK 2.17T | CZK 21,000.22 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | CZK 51.3B | CZK 772.2B | CZK 1,900.51 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | CZK 38.1B | CZK 698B | CZK 1,132.04 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | CZK 36.8B | CZK 444.4B | CZK 3,318.17 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | CZK 34.6B | CZK 546.1B | CZK 12,822.72 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | CZK 31.5B | CZK 623.3B | CZK 860.19 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | CZK 30.9B | CZK 353.2B | CZK 5,502.97 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | CZK 29.4B | CZK 516.4B | CZK 450.42 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | CZK 29.1B | CZK 264.3B | CZK 1,364.36 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | CZK 25.4B | CZK 3.55T | CZK 623.21 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | CZK 21.9B | CZK 111.8B | CZK 1,337.71 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | CZK 20.3B | CZK 128B | CZK 188.12 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | CZK 20B | CZK 70B | CZK 360.91 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | CZK 15.2B | CZK 393.8B | CZK 6,004.03 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | CZK 13.7B | CZK 877B | CZK 1,525.16 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | CZK 12.7B | CZK 163B | CZK 1,861.86 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | CZK 12.7B | CZK 337.5B | CZK 1,732.60 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | CZK 12.1B | CZK 296.4B | CZK 593.01 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | CZK 11.3B | CZK 583.7B | CZK 2,660.76 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | CZK 8.6B | CZK 174.9B | CZK 1,040.54 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | CZK 8.3B | CZK 101.3B | CZK 608.33 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | CZK 7.9B | CZK 189.5B | CZK 6,778.27 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | CZK 7.8B | CZK 140.9B | CZK 3,469.87 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | CZK 7.2B | CZK 156.5B | CZK 2,976.14 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | CZK 6.9B | CZK 107.5B | CZK 617.66 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | CZK 6.6B | CZK 134.1B | CZK 2,054.20 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | CZK 6.3B | CZK 169.3B | CZK 485.95 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | CZK 5.7B | CZK 88.5B | CZK 646.76 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 5B | CZK 135.4B | CZK 957.47 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | CZK 5B | CZK 186.5B | CZK 233.21 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 4.4B | CZK 205.4B | CZK 8,841.36 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | CZK 3.9B | CZK 132.7B | CZK 6,634.35 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 3.7B | CZK 165.9B | CZK 2,111.06 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 3.6B | CZK 277.4B | CZK 332.71 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | CZK 2.9B | CZK 184.3B | CZK 2,824.22 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | CZK 2.7B | CZK 158.8B | CZK 1,139.82 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | CZK 2.7B | CZK 164.8B | CZK 1,505.62 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | CZK 2.1B | CZK 107.1B | CZK 1,115.83 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | CZK 1.9B | CZK 214B | CZK 2,253.43 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | CZK 1.8B | CZK 222B | CZK 1,468.53 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | CZK 1.6B | CZK 107.3B | CZK 305.61 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | CZK 1.4B | CZK 100.6B | CZK 918.83 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 1.2B | CZK 183.3B | CZK 2,643.88 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | CZK 1.1B | CZK 105B | CZK 1,865.20 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | CZK 1B | CZK 144.2B | CZK 2,126.39 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | CZK 483.4M | CZK 117B | CZK 2,773.14 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2100 CZK).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (CZK 437.7B), Merck & Co (CZK 323.5B) and Novartis (CZK 254B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 18 Nov 2026, 22:14 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of CZK 112.36T as of 18 Nov 2026, 22:14 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.